Precision for Medicine is proud to be attending the 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit in Vienna, Austria. If you are in attendance, be sure to set up a meeting with Houria Bachtarzi or André Bongartz, and don’t miss Houria’s presentation on ”The Double-edge Sword of Innovative Therapies – Evolving CMC Challenges and Expectations for Gene and Cell Therapy Development”, June 20th at 10:10am CEST. Schedule a meeting here.
Precision for Medicine is part of the Precision Medicine Group, an integrated team of experts that extends Precision for Medicine’s therapeutic development capabilities beyond approval and into launch strategies, marketing communication, and payer insights. As one company, the Precision Medicine Group helps pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.